These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7378115)

  • 21. Recommendations for fluoride varnish use in caries management.
    Autio-Gold J
    Dent Today; 2008 Jan; 27(1):64-7; quiz 67, 58. PubMed ID: 18240633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo studies of an NaF impregnated toothpick.
    Petersson LG; Kashani H; Birkhed D
    Swed Dent J; 1994; 18(3):69-73. PubMed ID: 8085219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides.
    Chambers MS; Mellberg JR; Keene HJ; Bouwsma OJ; Garden AS; Sipos T; Fleming TJ
    Oral Oncol; 2006 Oct; 42(9):934-45. PubMed ID: 16891149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoride pharmacokinetics in the domestic pig.
    Richards A; Fejerskov O; Ekstrand J
    J Dent Res; 1982 Sep; 61(9):1099-102. PubMed ID: 6963284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of fluoride from dietary sepiolite in the lamb.
    Chaso A; Pascual R; Madrid JA; Salido GM
    Ann Rech Vet; 1991; 22(1):71-5. PubMed ID: 1828334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium fluoride or sodium monofluorophosphate? A critical view of a meta-analysis on their relative effectiveness in dentifrices.
    Holloway PJ; Worthington HV
    Am J Dent; 1993 Sep; 6 Spec No():S55-8. PubMed ID: 7488357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results from a three-year caries clinical trial comparing NaF and SMFP fluoride formulations.
    Marks RG; Conti AJ; Moorhead JE; Cancro L; D'Agostino RB
    Int Dent J; 1994 Jun; 44(3 Suppl 1):275-85. PubMed ID: 7960166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in dental caries with four concentrations of sodium fluoride in a dentifrice: a meta-analysis evaluation.
    Bartizek RD; Gerlach RW; Faller RV; Jacobs SA; Bollmer BW; Biesbrock AR
    J Clin Dent; 2001; 12(3):57-62. PubMed ID: 11505961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative anti-caries effects of tablet and liquid fluorides in cleft children.
    Lin YT; Tsai CL
    J Clin Dent; 2000; 11(4):104-6. PubMed ID: 11460274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention. Part 7: professionally applied topical fluorides for caries prevention.
    Hawkins R; Locker D; Noble J; Kay EJ
    Br Dent J; 2003 Sep; 195(6):313-7. PubMed ID: 14512991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caries-preventive effects of sodium and amine fluoride dentifrices.
    Warrick JM; Miller LL; Doan EJ; Stookey GK
    Am J Dent; 1999 Feb; 12(1):9-13. PubMed ID: 10477992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.
    Warneke G; Setnikar I
    Arzneimittelforschung; 1993 May; 43(5):584-90. PubMed ID: 8329004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.
    Devogelaer JP; Nagant de Deuxchaisnes C; Stein F
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S75-9. PubMed ID: 2339640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative anticaries effectiveness of sodium monofluorophosphate and sodium fluoride as contained in currently available dentifrice formulations.
    DePaola PF; Soparkar PM; Triol C; Volpe AR; Garcia L; Duffy J; Vaughan B
    Am J Dent; 1993 Sep; 6 Spec No():S7-12. PubMed ID: 7488359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoride mechanisms.
    ten Cate JM; van Loveren C
    Dent Clin North Am; 1999 Oct; 43(4):713-42, vii. PubMed ID: 10553252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoride release and caries inhibition associated with a resin-modified glass-ionomer cement at varying fluoride loading doses.
    Donly KJ; Segura A
    Am J Dent; 2002 Feb; 15(1):8-10. PubMed ID: 12074234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticaries potential of commercial dentifrices as determined by fluoridation and remineralization efficiency.
    Casals E; Boukpessi T; McQueen CM; Eversole SL; Faller RV
    J Contemp Dent Pract; 2007 Nov; 8(7):1-10. PubMed ID: 17994149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fluoride prophylaxis in Winterthur. Way to optimization].
    Ziegler H
    Swiss Dent; 1991; 12(1):20-2. PubMed ID: 1853421
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparative anticaries efficacy of a dentifrice containing 0.3% triclosan and 2.0% copolymer in a 0.243% sodium fluoride/silica base and a dentifrice containing 0.243% sodium fluoride/silica base: a two-year coronal caries clinical trial on adults in Israel.
    Mann J; Vered Y; Babayof I; Sintes J; Petrone ME; Volpe AR; Stewart B; De Vizio W; McCool JJ; Proskin HM
    J Clin Dent; 2001; 12(3):71-6. PubMed ID: 11505964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.